Pressreleases

Securing your end-to-end supply chain

Supply chain safety, quality and reliability are key to all our Quats and Insulin Human customers. Here is how we can help you secure your supply chain, from sourcing raw materials to delivering your products as promised – even in a global crisis.

A Strong Signal in Turbulent Times: Vetter Achieves Carbon Dioxide-Neutral Levels

Contract Development and Manufacturing Organization further expands its commitment to climate protection.

LTS and LIVZON Enter License and Collaboration Agreement to Develop and Commercialize ASENAPINE TTS

LTS Lohmann Therapie-Systeme AG (LTS), a world-class pharmaceutical technology company headquartered in Andernach, Germany, and Livzon Pharmaceutical Group Inc. (Livzon),

7P Solutions Hires Senior Level New Business Development Executive to Help Manage Growth and Additional Sales

7P has hired Drew Hecht as their new Vice- President of Pharmaceutical Solutions. Drew joins a team of motivated executives

Gerresheimer supplies the primary packaging for dexamethasone

Gerresheimer has been commissioned by a well-known customer to produce plastic containers in which the active ingredient dexamethasone is to be filled.

Vetter Further Expands its Development Service with New Site in Austria

Vetter, a leading global contract development and manufacturing organization (CDMO), is further investing in additional capacity to meet that growing global demand with the purchase of a clinical manufacturing site in Austria.  

SGS Joins with Biophytis to Launch Its International Clinical Trial of COVID-19 Related Respiratory Failure Treatment

SGS, the world’s leading inspection, verification, testing and certification company, has received approval from Belgium’s Federal Agency for Medicines and

Rentschler Biopharma and Vetter Team Up with Joint Goal to Simplify Processes and Optimize Time-to-Market

Vetter and Rentschler Biopharma, two globally operating Contract Development and Manufacturing Organizations (CDMOs), today announced their strategic collaboration, to enhance

Injection vials for vaccines for protection against Covid-19

The vaccines under development to protect against Covid-19 are, like many other drugs, filled in so-called injection or vials made of type 1 borosilicate glass, also known as vials. The large worldwide demand for vials is met by the Gerresheimer Group's plants in Europe, America and Asia, where they are manufactured to high-quality standards for customers in the pharmaceutical industry.